• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Tissum rases €39m

November 21, 2019 By Sean Whooley

Programmable polymer developer Tissium announced that it raised nearly $43 million in a Series B funding round to support expansion.

The company’s funding round reached approximately $42.8 million (€38.8 million) and included new investors BNP Paribas Developpement, the European Investment Fund, M&L Investments and ValQuest Partners, along with returning investors Bpifrance, CM-CIC Innovation, CapDecisif Management, Omnes Capital and Soffinnova Partners.

Paris-based Tissium said the funds raised will be put toward the global expansion of its platform of fully synthetic, biomorphic programmable polymers. The polymers are designed for use in numerous therapeutic fields, such as nerve repair, cardiovascular and gastroenterology.

Tissium’s platform was developed at the Massachusetts Institute of Technology and Brigham and Women’s Hospital in Boston, creating polymers designed to go inside the body as sealants, adhesives, barriers, plugs or as a vehicle for drug delivery. The company said the funding will not only support the platform’s growth, but it’s expected to support a strategy for creating a clinical development and regulatory process, particularly in the U.S., out of Tissium’s Boston affiliate office.

“This new round of funding is a testament to the support we continue to receive from investors for our strategy and vision for the broad Tissium ecosystem of products that we have in development,” Tissium CEO Cristophe Bancel said in a news release. “We look forward to moving swiftly towards multiple verticals and expanding into new clinical fields in the coming months.”

In addition to the funding, Tissium announced that medtech entrepreneur and executive Jay Watkins is joining the company’s board of directors as an independent chairman.

“We are thrilled to have Jay joining our board as chairman,” Bancel said. “He brings tremendous experience and depth in building innovative medtech companies into next-generation leaders and will allow us to shape and expand our ecosystem into multiple verticals. I take the opportunity to thank our co-founder, Bernard Gilly, co-founder and chairman of iBionext, who has led the company as its chairman since our inception.”

“I am delighted to join Tissium as chairman,” Watkins added. “I have been impressed with the breadth of applications for its biomorphic programmable polymers across a wide range of therapeutic fields. The organization has already demonstrated its ability to innovate and create novel product opportunities and I look forward to working with the team to extend our impact in the medtech space.”

Filed Under: Business/Financial News, Featured, Funding Roundup, Personnel Tagged With: Brigham & Women's Hospital, Mass. Institute of Technology, Tissium

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS